Therapeutic monoclonal antibodies are FDA/EMA approved drugs for the treatment of various diseases. The validity, specificity, and reproducibility of these antibodies have been proven in the clinical setting. Therapeutic monoclonal antibodies are now available for research use at 1mg/ml in phosphate buffered saline (PBS) buffer.
Our Products(Reference Drugs as Dilutions) | Antigen | Original Drug Brand | Volume per Vial [µL] | Quantity per vial [mg] | |
|---|---|---|---|---|---|
Adalimumab |
TNF-α |
Humira |
100 |
0,1 |
|
Bevacizumab |
VEGF-A |
Avastin |
100 |
0,1 |
|
Cetuximab |
EGFR |
Erbitux |
100 |
0,1 |
|
Daratumumab |
CD38 |
Darzalex |
100 |
0,1 |
|
Denosumab |
RANKL |
Prolia |
100 |
0,1 |
|
Etanercept |
TNF-α |
Enbrel |
100 |
0,1 |
|
Golimumab |
TNF-α |
Simponi |
100 |
0,1 |
|
Infliximab |
TNF-α |
Remicade |
100 |
0,1 |
|
Nivolumab |
PD-1 |
Opdivo |
100 |
0,1 |
|
Obinutuzumab |
CD20 |
Gazyvaro |
100 |
0,1 |
|
Palivizumab |
RSV protein F |
Synagis |
100 |
0,1 |
|
Pembrolizumab |
PD-1 |
Keytruda |
100 |
0,1 |
|
Ramucirumab |
VEGFR2 |
Cyramza |
100 |
0,1 |
|
Rituximab |
CD20 |
Mabthera |
100 |
0,1 |
|
Secukinumab |
IL-17 |
Cosentyx |
100 |
0,1 |
|
Tocilizumab |
IL-6 R |
RoActemra |
100 |
0,1 |
|
Trastuzumab |
HER2 |
Herceptin |
100 |
0,1 |
|
Ustekinumab |
IL-12 |
Stelara |
100 |
0,1 |
We generate therapeutic antibody (1 mg/ml) dilutions by diluting Evidentic’s drug aliquots with PBS
Concentration: 1mg/ml
Buffer: PBS pH 7.4 (+ traces of original drug buffer)
Storage temperature: -80°C
Shipping time EU: 2 days / US: 3-4 days
1. We purchase reference antibody drugs
2. .. we aliquot the drug…
3. .. and dilute with PBS to 1mg/ml.
